3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
2
Gynecologic
2
Gastrointestinal
2
Conditions
Stomach Neoplasms
3
Ovarian Neoplasms
3
Peritoneal Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Pleural Effusion
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Liposarcoma
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Ascites
1
Appendiceal Neoplasms
1
Interventions
Pemetrexed
40
Cisplatin
35
pembrolizumab
21
Nivolumab
17
Carboplatin
16
Ipilimumab
13
Gemcitabine
10
Cyclophosphamide
9
fludarabine
6
durvalumab
6
Bevacizumab
6
Radiotherapy, Intensity-Modulated
4
LMB-100
4
Drug Therapy
4
Dexamethasone
4
tremelimumab
3
tazemetostat
3
spartalizumab
3
olaparib
3
niraparib
3
atezolizumab
3
anetumab ravtansine
3
amatuximab
3
Vinorelbine
3
Paclitaxel
3
Oxaliplatin
3
Imatinib Mesylate
3
Fluorouracil
3
Cerebral Decortication
3
Blood Specimen Collection
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Mesothelioma
×
Hyperthermic Intraperitoneal Chemotherapy
×
Thoracic
×
Clear all
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled